Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer
A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer. The findings, from an international clinical trial led by Dana-Farber Cancer Institute researchers, reinforce earlier findings of the benefits of the drug … Read more
/cdn.vox-cdn.com/uploads/chorus_asset/file/23957252/acastro_190204_1777_privacy_0002.jpg "FTC study: social media and video streaming companies are spying on users")
